13D Filing: RA Capital Management and Wave Life Sciences Ltd (WVE)

Page 3 of 5 – SEC Filing

 

1

Names of Reporting Persons.

 

Peter Kolchinsky

2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a) [ ]
(b) [ ]
3 SEC Use Only
4

Source of Funds (See Instructions):

AF

5

Check if disclosure of legal proceedings
is required pursuant to Items 2(d) or 2(e):

[ ]

6

Citizenship or Place of Organization. United
States

 

Number

of Shares

Beneficially

Owned by

Each

Reporting

Person With

7       Sole
Voting Power 0 shares

8       Shared
Voting Power 7,512,049 shares

9
Sole Dispositive Power 0 shares

10      Shared
Dispositive Power 7,512,049 shares

11

Aggregate Amount Beneficially Owned by
Each Reporting Person

7,512,049 shares

12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions)     [ ]
13

Percent of Class Represented by Amount
in Row (11)

27.0%2

14

Type of Reporting Person (See Instructions)

HC, IN

____________________________

2 The reporting person is the
beneficial owner of 7,512,049 shares of the Issuer’s Ordinary Shares which constitute approximately 27.0% of the class outstanding.
The percentage calculation assumes that there are currently 27,790,022 outstanding shares of Common Stock of the Issuer, based
on the Issuer’s Form 10-Q as filed with the Securities and Exchange Commission (“SEC”) on November 09, 2017.

Follow Wave Life Sciences Ltd.